{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T11:56:33Z","timestamp":1761998193452,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81502881"],"award-info":[{"award-number":["81502881"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2015M582351"],"award-info":[{"award-number":["2015M582351"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Nature Science Foundation of Hunan province","doi-asserted-by":"crossref","award":["2017JJ3428"],"award-info":[{"award-number":["2017JJ3428"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Health Prev Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12199-017-0649-0","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T08:43:00Z","timestamp":1493023380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis\/occlusion disease in a Chinese population"],"prefix":"10.1186","volume":"22","author":[{"given":"Tong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congrong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoXiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"649_CR1","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22542. doi:\n10.1371\/journal.pone.0022542\n\n.","journal-title":"PLoS One"},{"issue":"1","key":"649_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340. doi:\n10.1038\/jhg.2010.132\n\n.","journal-title":"J Hum Genet"},{"key":"649_CR3","doi-asserted-by":"publisher","first-page":"e48179","DOI":"10.1371\/journal.pone.0048179","volume":"7","author":"Z Wu","year":"2012","unstructured":"Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One. 2012;7:e48179. doi:\n10.1371\/journal.pone.0048179\n\n.","journal-title":"PLoS One"},{"issue":"12","key":"649_CR4","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1161\/STROKEAHA.112.663864","volume":"43","author":"S Miyawaki","year":"2012","unstructured":"Miyawaki S, Imai H, Takayanagi S, Mukasa A, Nakatomi H, Saito N. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis\/occlusion. Stroke. 2012;43(12):3371\u20134. doi:\n10.1161\/STROKEAHA.112.663864\n\n.","journal-title":"Stroke"},{"issue":"5","key":"649_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2176\/nmc.52.299","volume":"52","author":"W Liu","year":"2012","unstructured":"Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo). 2012;52(5):299\u2013303.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"10","key":"649_CR6","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/STROKEAHA.113.002477","volume":"44","author":"S Miyawaki","year":"2013","unstructured":"Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Mukasa A, et al. Genetic variant RNF213 c.14576G\u2009>\u2009A in various phenotypes of intracranial major artery stenosis\/occlusion. Stroke. 2013;44(10):2894\u20137. doi:\n10.1161\/STROKEAHA.113.002477\n\n.","journal-title":"Stroke"},{"issue":"11","key":"649_CR7","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","volume":"45","author":"AC Cecchi","year":"2014","unstructured":"Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, et al. RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke. 2014;45(11):3200\u20137. doi:\n10.1161\/STROKEAHA.114.006244\n\n.","journal-title":"Stroke"},{"key":"649_CR8","doi-asserted-by":"publisher","unstructured":"Moteki Y, Onda H, Kasuya H, Yoneyama T, Okada Y, Hirota K, et al. Systematic validation of RNF213 coding variants in Japanese patients with moyamoya disease. J Am Heart Assoc. 2015;4(5). doi:\n10.1161\/JAHA.115.001862\n\n.","DOI":"10.1161\/JAHA.115.001862"},{"issue":"6","key":"649_CR9","doi-asserted-by":"publisher","first-page":"e0130663","DOI":"10.1371\/journal.pone.0130663","volume":"10","author":"OY Bang","year":"2015","unstructured":"Bang OY, Ryoo S, Kim SJ, Yoon CH, Cha J, Yeon JY, et al. Adult moyamoya disease: a burden of intracranial stenosis in East Asians? PLoS One. 2015;10(6):e0130663. doi:\n10.1371\/journal.pone.0130663\n\n.","journal-title":"PLoS One"},{"issue":"11","key":"649_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G\u2009>\u2009A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78(11):803\u201310. doi:\n10.1212\/WNL.0b013e318249f71f\n\n.","journal-title":"Neurology"},{"issue":"5","key":"649_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.01.005","volume":"24","author":"S Miyawaki","year":"2015","unstructured":"Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Nakatomi H, et al. Genetic analysis of RNF213 c.14576G\u2009>\u2009A variant in nonatherosclerotic quasi-moyamoya disease. J Stroke Cerebrovasc Dis. 2015;24(5):1075\u20139. doi:\n10.1016\/j.jstrokecerebrovasdis.2015.01.005\n\n.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"649_CR12","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1161\/STROKEAHA.116.012751","volume":"47","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Lee JK, Ahn SH, Kim BJ, Kang DW, Kim JS, et al. Nonatheroscleotic isolated middle cerebral artery disease may be early manifestation of moyamoya disease. Stroke. 2016;47(9):2229\u201335. doi:\n10.1161\/STROKEAHA.116.012751\n\n.","journal-title":"Stroke"},{"issue":"6","key":"649_CR13","doi-asserted-by":"publisher","first-page":"e0156607","DOI":"10.1371\/journal.pone.0156607","volume":"11","author":"OY Bang","year":"2016","unstructured":"Bang OY, Chung JW, Cha J, Lee MJ, Yeon JY, Ki CS, et al. A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis. PLoS One. 2016;11(6):e0156607. doi:\n10.1371\/journal.pone.0156607\n\n.","journal-title":"PLoS One"},{"issue":"2","key":"649_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12199-012-0299-1","volume":"18","author":"A Koizumi","year":"2013","unstructured":"Koizumi A, Kobayashi H, Liu W, Fujii Y, Senevirathna ST, Nanayakkara S, et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure [J]. Environ Health Prev Med. 2013;18(2):121\u20139. doi:\n10.1007\/s12199-012-0299-1\n\n.","journal-title":"Environ Health Prev Med"},{"issue":"5","key":"649_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12199-016-0549-8","volume":"21","author":"Y Cao","year":"2016","unstructured":"Cao Y, Kobayashi H, Morimoto T, Kabata R, Harada KH, Koizumi A. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population. Environ Health Prev Med. 2016;21(5):387\u201390. doi:\n10.1007\/s12199-016-0549-8\n\n.","journal-title":"Environ Health Prev Med"},{"key":"649_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12881-015-0252-4","volume":"16","author":"MA Jang","year":"2015","unstructured":"Jang MA, Shin S, Yoon JH, Ki CS. Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals [J]. BMC Med Genet. 2015;16:109. doi:\n10.1186\/s12881-015-0252-4\n\n.","journal-title":"BMC Med Genet"},{"issue":"2","key":"649_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.gene.2013.05.083","volume":"526","author":"X Wang","year":"2013","unstructured":"Wang X, Zhang Z, Liu W, Xiong Y, Sun W, Huang X, et al. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of moyamoya disease in Han Chinese human subjects. Gene. 2013;526(2):437\u201342. doi:\n10.1016\/j.gene.2013.05.083\n\n.","journal-title":"Gene"},{"key":"649_CR18","doi-asserted-by":"publisher","unstructured":"Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, et al. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg. 2017;126(4):1106\u201313. doi:\n10.3171\/2016.2.JNS152173\n\n.","DOI":"10.3171\/2016.2.JNS152173"},{"key":"649_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocn.2015.11.035","volume":"32","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cheng D, Zhang J, Zhao W. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: a case\u2013control study and meta-analysis. J Clin Neurosci. 2016;32:14\u20138. doi:\n10.1016\/j.jocn.2015.11.035\n\n.","journal-title":"J Clin Neurosci"},{"key":"649_CR20","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1038\/srep04442","volume":"4","author":"D Morito","year":"2014","unstructured":"Morito D, Nishikawa K, Hoseki J, Kitamura A, Kotani Y, Kiso K, et al. Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep. 2014;4:4442. doi:\n10.1038\/srep04442\n\n.","journal-title":"Sci Rep"},{"issue":"7","key":"649_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1365-2443.2001.00447.x","volume":"6","author":"T Ogura","year":"2001","unstructured":"Ogura T, Wilkinson AJ. AAA+ superfamily ATPases: common structure--diverse function. Genes Cells. 2001;6(7):575\u201397.","journal-title":"Genes Cells"},{"issue":"15","key":"649_CR22","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1073\/pnas.95.15.8630","volume":"95","author":"BV Geisbrecht","year":"1998","unstructured":"Geisbrecht BV, Collins CS, Reuber BE, Gould SJ. Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders zellweger syndrome, neonatal adrenoleukodystrophy, and infantile refsum disease. Proc Natl Acad Sci U S A. 1998;95(15):8630\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"649_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng1297-445","volume":"17","author":"BE Reuber","year":"1997","unstructured":"Reuber BE, Germain-Lee E, Collins CS, Morrell JC, Ameritunga R, Moser HW, et al. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet. 1997;17(4):445\u20138.","journal-title":"Nat Genet"},{"issue":"9","key":"649_CR24","doi-asserted-by":"publisher","first-page":"2231.e1","DOI":"10.1016\/j.neurobiolaging.2012.04.005","volume":"33","author":"Y Abramzon","year":"2012","unstructured":"Abramzon Y, Johnson JO, Scholz SW, Taylor JP, Brunetti M, Calvo A, et al. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(9):2231.e1\u20136. doi:\n10.1016\/j.neurobiolaging.2012.04.005\n\n.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"649_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12199-015-0498-7","volume":"21","author":"A Koizumi","year":"2016","unstructured":"Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S, et al. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med. 2016;21(2):55\u201370. doi:\n10.1007\/s12199-015-0498-7\n\n.","journal-title":"Environ Health Prev Med"},{"issue":"4","key":"649_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1161\/01.STR.17.4.648","volume":"17","author":"LR Caplan","year":"1986","unstructured":"Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17(4):648\u201355.","journal-title":"Stroke"},{"issue":"5","key":"649_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245\u201366.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"649_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","volume":"43","author":"L Duan","year":"2012","unstructured":"Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke. 2012;43(1):56\u201360. doi:\n10.1161\/STROKEAHA.111.621300\n\n.","journal-title":"Stroke"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12199-017-0649-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T11:19:35Z","timestamp":1526642375000},"score":1,"resource":{"primary":{"URL":"http:\/\/environhealthprevmed.biomedcentral.com\/articles\/10.1186\/s12199-017-0649-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1186\/s12199-017-0649-0","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"type":"print","value":"1342-078X"},{"type":"electronic","value":"1347-4715"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"article-number":"41"}}